A Phase III, Multicenter, Open Label, Randomized Study of Bovine Rotavirus Pentavalent Vaccine (BRV-PV) to Evaluate Lot-To-Lot Consistency and to Investigate Potential Interference With Routine UIP Vaccinations in Healthy Infants in India.

Trial Profile

A Phase III, Multicenter, Open Label, Randomized Study of Bovine Rotavirus Pentavalent Vaccine (BRV-PV) to Evaluate Lot-To-Lot Consistency and to Investigate Potential Interference With Routine UIP Vaccinations in Healthy Infants in India.

Completed
Phase of Trial: Phase III

Latest Information Update: 06 Oct 2017

At a glance

  • Drugs Bovine rotavirus vaccine reassortant (Primary) ; Hib-DTaP-hepatitis B vaccine; Poliovirus vaccine; Rotavirus vaccine
  • Indications Rotavirus infections
  • Focus Pharmacodynamics; Registrational
  • Sponsors Serum Institute of India
  • Most Recent Events

    • 03 Oct 2017 Status changed from active, no longer recruiting to completed.
    • 08 Mar 2017 Planned End Date changed from 1 Aug 2016 to 1 Apr 2017.
    • 08 Mar 2017 Status changed from recruiting to active, no longer recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top